Heterocyclic compound and use thereof
AssigneeTakeda Pharmaceutical Company Limited
InventorsMasakuni Kori, Toshihiro Imaeda, Shinji Nakamura, Masashi Toyofuku, Eiji Honda, Yasutomi Asano, Osamu Ujikawa, Michiyo Mochizuki
Life of this patent
Estimating the term…
Abstract
Provided is a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimer's disease or attention deficit hyperactivity disorder (ADHD) and the like.
Claims2
9-(4-Phenoxyphenyl)-3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising 9-(4-phenoxyphenyl) -3,4-dihydropyrido[2,1-c][1,2,4]thiadiazine 2,2-dioxide or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.